IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#117
Positioning
Market Dominance
Manufacturing
Consumer Goods
$88.1B
Pending
Detailed business profile pending verification.
Headcount
—
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = HLN ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$HLN Haleon plc | 69 | 80 | 84 | 53 | 56.0x | 5.0x | 36.5% | 17.2% | 60.8% | 19.6% | 13.1% | -2.3% | 2.8% | 64.0x | $88.1B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Haleon plc (HLN) receives a "Buy" rating with a composite score of 69.2/100. It ranks #117 out of 7,333 stocks in our coverage universe and carries a 4-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Executive Directory Unavailable for HLN
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
80
49
95
Audit Verdict: High quality, disciplined capital allocation, and low volatility suggest strong governance.
No recent insider transactions available for HLN
HQ Base
WEYBRIDGE,
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Top-rated overall — multiple factors aligned for strong entry
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for HLN.
View All RatingsConservative accounting — High cash conversion efficiency
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 80 | 91 | -11DRAG |
| MOMENTUM | 53 | 43 | +10ALPHA |
| VALUATION | 84 | 85 | -1NEUTRAL |
| INVESTMENT | 49 | 90 | -41DRAG |
| STABILITY | 95 | 99 | -4NEUTRAL |
| SHORT INT | 72 | 83 | -11DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 20.9% vs WACC 8.3% (spread +12.5%)
GM 61% vs sector 43%, OM 20% vs sector 1%
Capital turnover 1.39x, R&D intensity 2.7%
Rev growth -2%, 2yr history
Interest coverage 5.7x, Net debt/EBITDA 3.3x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Haleon plc receives a Buy rating with a composite score of 69.2/100 and 4 out of 5 stars, ranking #117 of 7,333 stocks in our universe. HLN displays a favorable combination of factors that positions it above the majority of the market. While not without risk, the quantitative profile supports a constructive outlook.
HLN earns a quality score of 80/100, indicating above-average business quality. The company reports a return on equity of 36.5% (sector avg: -2.5%), gross margins of 60.8% (sector avg: 42.5%), net margins of 13.1% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
HLN carries a solid value score of 84/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 56.02x, an EV/EBITDA of 4.95x, a P/B ratio of 2.48x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
With an investment score of 49/100, HLN exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of -2.3% vs. a sector average of 5.9% and a return on assets of 17.2% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
HLN demonstrates moderate momentum with a score of 53/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -2.3% year-over-year, while a beta of 0.20 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
Haleon plc earns an excellent stability score of 95/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.20 and a debt-to-equity ratio of 64.00x (sector avg: 0.2x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
HLN carries a short interest score of 72/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 64.00x). At $88.1B market cap (large-cap), Haleon plc offers reasonable institutional liquidity.
HLN pays a solid dividend yield of 2.8%, contributing an income component to total returns. This moderate yield suggests a balance between returning capital to shareholders and retaining earnings for reinvestment — a common profile among quality compounders.
Haleon plc is a large-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #117 of 7,333 overall (98th percentile). Key comparisons include ROE of 36.5% exceeding the -2.5% sector median and operating margins of 19.6% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
Quant Factor Profile
Key factor gap
Stability (95) vs Investment (49) — closing this gap could shift the rating.
EV/EBITDA 57% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 1572% BELOW SECTOR MEDIAN
Gross Margin 43% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate Haleon plc (HLN) as a Buy with a composite score of 69.2/100 at a current price of $11.07. The stock scores above average across the majority of our six quantitative factors and ranks #117 out of 7,333 stocks in our universe, reflecting a favorable risk-reward profile.
The rating is primarily driven by strength in stability (95th percentile) and value (84th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (55/100), Low uncertainty, and Exemplary capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Haleon plc holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 69.2/100 places it at rank #117 in our full 7,333-stock universe. With a $88.1B market capitalization, Haleon plc operates at meaningful scale within the Manufacturing sector, providing competitive advantages in distribution, procurement, and customer reach.
Revenue contraction of -2% combined with momentum at the 53th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 61% (+18.3pp vs sector) narrow to operating margins of 20% (+18.4pp vs sector) and net margins of 13.1%, yielding a gross-to-net conversion rate of 22%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $11.07, Haleon plc appears undervalued relative to its fundamentals. Our value factor score of 84/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 56.0x (a 152% premium to the sector median of 22.3x), EV/EBITDA of 5.0x (discounted to peers), P/B of 2.5x, P/S of 0.9x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis partially supports given strong quality metrics.
The stock's Buy rating (composite score 69.2/100) reflects broad-based quantitative strength, placing it in the top 20% of our 7,333-stock universe.
Gross margins of 61% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 36.5% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 84/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
A 2.76% dividend yield provides income while you wait, and dividends historically account for a significant portion of total equity returns.
We assign a Low uncertainty rating to Haleon plc. The company exhibits strong financial stability with a beta of 0.20, and a stability factor in the 95th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
Specific risk factors that inform our assessment include: low beta of 0.20 — while defensive, this may indicate limited upside participation in bull markets; elevated valuation multiple (P/E 56.0x) that leaves limited margin for error. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 95th percentile and quality factor at the 80th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 61% provide a buffer against cost pressures; above-average stability (95th percentile) suggests predictable business dynamics; large-cap scale ($88.1B) provides resilience. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate Haleon plc's capital allocation as Exemplary. Management demonstrates a strong track record of balancing reinvestment with shareholder returns, evidenced by returns on equity of 36.5%, a 2.76% dividend yield. Exemplary allocators typically generate returns on equity above 20% while maintaining debt-to-equity below 50% — Haleon plc meets this high bar.
The balance sheet remains conservatively managed, providing financial flexibility for opportunistic investments while maintaining a margin of safety for shareholders. The company returns capital via a 2.76% dividend yield, and the combination of 17.2% return on assets and controlled leverage suggests management is deploying capital at rates well above the cost of capital — the hallmark of exemplary stewardship.
In summary, Haleon plc receives a Buy rating with a composite score of 69.2/100 (rank #117 of 7,333). Our quantitative framework assigns a Narrow Moat (55/100, trend: stable), Low uncertainty, and Exemplary capital allocation. The average factor score across quality, value, momentum, stability, and investment is 72/100.
Our analysis supports a constructive view on Haleon plc. The combination of identifiable competitive advantages, low uncertainty, and exemplary capital allocation creates a risk-reward profile that favors accumulation at current levels. We recommend investors consider adding this name to portfolios aligned with the stock's risk profile.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign Haleon plc a Narrow Moat rating with a composite moat score of 55/100. The ROIC-WACC spread of +12.5% is the primary signal of economic value creation. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that Haleon plc can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being margin superiority at 17.9/20.
The strongest moat sources are margin superiority (17.9/20) and economic value creation (15.9/20). GM 61% vs sector 43%, OM 20% vs sector 1%. ROIC 20.9% vs WACC 8.3% (spread +12.5%). These pillars form the core of Haleon plc's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (3.1/20) and growth durability (8.3/20). Capital turnover 1.39x, R&D intensity 2.7%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Haleon plc's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 61% providing a solid profitability foundation, operating margins of 20% reflecting effective cost management, declining revenues (-2%) that pressure the earnings outlook. The margin cascade from 61% gross to 20% operating to 13.1% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 80th percentile.
The margin profile shows gross margins of 61%, operating margins of 20%, net margins of 13.1%. Return metrics include ROE of 36.5% and ROA of 17.2%. Relative to the Manufacturing sector, gross margins are 18.3 percentage points above the sector median of 43%, and ROE of 36.5% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 64%, a dividend yield of 2.76%, revenue growth of -2%. The sector median D/E is 0%, putting Haleon plc at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
A P/E of 56.0x leaves little room for execution misses — any earnings disappointment could trigger a sharp multiple compression.
Revenue decline of -2% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Elevated short interest (72th percentile) indicates that sophisticated market participants are betting against the stock.
Above 50MA
37.18%
Net New Highs
+51081

Pfizer has sold its remaining 7.3% stake in Haleon for $3.1 billion, fully exiting its position in the company. Haleon expects 2025 organic revenue growth of 4% to 6%, with stronger performance in the second half.

Haleon, the maker of Sensodyne toothpaste, reported a 0.6% decline in revenue for 2024 but expects 4-6% organic revenue growth in 2025, with stronger performance in the second half of the year. The company faces foreign exchange headwinds that may impact revenue and profit.

Pfizer's stock has fallen over 60% since its peak during the pandemic, but the company is showing signs of recovery with revenue growth and a robust drug pipeline. The stock is trading at a value with a high dividend yield, making it an attractive investment opportunity.

Pfizer's COVID-19 products continue to generate significant cash flow, helping bolster the company's dividend. Pfizer's ability to monetize assets and its new product pipeline also contribute to the safety of its ultra-high-yield dividend.